The report that 2,5-dihydroxyphenylpyruvic acid occurs in the urine of patients with collagen disease has not been confirmed, and no evidence was found for regarding collagen disease as being due to an inherent error in tyrosine metabolism as suggested by Japanese workers.
It has recently been claimed that in the urine of patients suffering from one or other of the collagen diseases there may be detected a postulated but hitherto unisolated intermediate of tyrosine metabolism, namely, 2,5-dihydroxyphenylpyruvic acid (Nishimura, Shibata, Yasui, and Okamoto, 1956 ). This substance was recognized by its purple fluorescence in ultra-violet light after paper chromatography. It was characterized by reduction of ammoniacal silver nitrate and Brigg's reagents and by reactions with ferric chloride, Fenton's and hydrazine reagents. Its chromatographic behaviour in two solvent systems and its ultra-violet absorption spectrum were found to be the same as those of a synthetic specimen of 2,5-dihydroxyphenylpyruvic acid. In the system * Present address: Department of Bacteriology, Edinburgh Royal Infirmary. n-butanol: acetic acid: water (4: 1: 1) two spots were obtained, depending on whether the urine was acid or neutral during its concentration; one of the spots was thought to be the quinone derivative of 2,5-dihydroxyphenylpyruvic acid and was seen also in chromatograms of the synthetic substance.
In 38 cases of collagen disease the urine contained the substance described. It was absent from the urine of normal persons, those suffering from a variety of other diseases, or unaffected relatives of patients with collagen disease. The authors concluded that a fundamental biochemical clue to the aetiology of collagen diseases had been found, and that these diseases must be grouped with phenylketonuria, alcaptonuria, tyrosinosis, and albinism in that they are caused by an inherent error in the metabolism of tyrosine.
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Examination of Urine for 2,5-Dihydroxyphenylpyruvic Acid
The Japanese workers' description of the preparation of urine extracts for chromatography was limited to the following paragraph: "Either as it was or acidified with 10% H2SO4, the 24-hr. urine of diffuse collagen disease patients was concentrated till about 20 ml. of it remained, and after another further treatment of it with 60% alcohol, and the resultant elimination of inorganic salts, the urine thus obtained was subjected to experiment. Then one-dimensional paper chromatography was performed." In an attempt to follow the above procedure 250 ml. of urine (freshly collected in acid to give a final pH of 3) from a case of acute rheumatoid arthritis was distilled at reduced pressure under nitrogen, the external temperature being kept below 40' C. until a few millilitres of viscous residue remained. This was taken up in alcohol to a concentration of 600, and centrifuged. The supernatant was subjected to chromatography overnight on Whatman No. I paper by the ascending technique using the solvent system specified by the Japanese workers (n-butanol:acetic acid: water 4:1:1). When viewed under ultra-violet light (" hanovia " medium pressure quartz arc with Wood's glass filter or " hanovia" chromatolite Hg resonance lamp 2537A) a large number of fluorescent areas was detectable and subsequent spraying with ammoniacal silver nitrate solution (0.1 N AgNO3 25 ml., ammonia S.G. 0.88 8 ml., water to 50 ml.) revealed a number of reducing substances. However, no fluorescent reducing substance was seen which had the RF value stipulated by Nishimura and his colleagues. Furthermore, and perhaps of especial importance in view of the number of closely related compounds into which the quinol sought might be transformed, no difference was detectable in urine from normal individuals and rheumatoid patients when chromatography was carried out in the butanol system or in phenol: water: H2S03, a solvent more suitable than the former for the preservation of a highly oxidizable substance (McMillan, 1957) .
An attempt was made to purify the urine before chromatography by adsorption upon alumina (McMillan, 1957 (Nishimura et al., 1958) , preceding reagents (see Smith, 1958 ), Millon's Roux reagent (Roux, 1951) and bromothymol blue-acidified potassium iodide-starch ammonia (as used for homogentisic acid by Consden, Forbes, Glynn, and Stanier, 1952) . The fluorescent substance was seen to develop a brown colour when the papers were exposed to the atmosphere for an hour or two; it was unstable in alkaline solution, a pH of 9 causing appreciable loss.
By consideration of the above properties and by comparing the observed RF in various solvent systems with those published for phenolic acids known to occur in urine (for references see Smith, 1958) , it appeared probable that the fluorescent substance was 3-hydroxyanthranilic acid. A specimen of this substance (Roche) Semiquantitative Measurement of the Amount of 3-Hydroxyanthranilic Acid in Urine The fluorescence of 3-hydroxyanthranilic acid (3-HAA) in ultra-violet light could be detected easily on the chromatogram paper in amounts as low as 0.25 jug., whereas none of the colour reactions was as sensitive as this. Chromatography in the butanol system was unsuited to quantitative work because very many phenolic acids have a similar high RF value; urine extracts prepared by simple ether extraction gave neighbouring spots which were highly fluorescent under ultra-violet light, and, though they could be distinguished from 3-hydroxyanthranilic acid by their blue colour, they partially, or sometimes completely, obscured the purple colour of 3-HAA. The benzene system was unsuitable because the spots became too spread out. Both the phenol and formate systems gave sharply defined spots and some urine extracts could be satisfactorily assessed in terms of standard amounts of 3-HAA run on the same sheets of paper. Many, however, showed one or more fluorescent substance which interfered more or less seriously with such a comparison. Two-dimensional chromatography, employing the phenol system followed by the formate, failed to eradicate the interference. After the use of any of the above solvent systems colour development on the paper with Ehrlich's reagent or buffered potassium ferricyanide solution proved insufficiently sensitive and ammoniacal silver nitrate or Gibbs reagent at various pH values insufficiently specific.
Owing to the presence of a basic group, 3-HAA is not extracted by ether from highly acid aqueous solution. When urine was acidified with one-tenth of its volume of concentrated HCI and extracted with ether, the concentrated ether extracts on chromatography usually contained much material fluorescent in ultra-violet light, whereas subsequent extraction of the aqueous residue after adjustment of the pH to 3 gave a preparation which frequently showed only one fluorescent area, that due to 3-HAA. These findings were applicable to chromatography in the phenol, formate, and butanol systems. At each pH ether was extracted with four equal portions whose total volume equalled that of the aqueous phase. Experiments showed that, when added to the urine in amounts as high as 1 jug. /ml., 3-HAA could be satisfactorily accounted for during the processes of extraction, concentration, and chromatography; the four combined extracts made at pH 3 contained as far as could be assessed by visual comparison the whole of the added 3-HAA, whereas the four ether extracts of the highly acid urine and two additional extracts made at pHI 3 subsequent to the four normally prepared showed no trace of 3-HAA.
After such a procedure of double ether extraction some urine extracts continued to give additional fluorescent spots.
Commonly there was found a blue spot immediately above the purple 3-HAA in both phenol and formate systems; the fluorescence of this substance was much greater under the "hanovia" 2537 A lamp than under the Woods glass whereas that of 3-HAA was similar under both, so that there was no danger of confusion. In order to guard against the possibility of interference at the actual site of 3-HAA, though this appeared unlikely, after assessment under ultra-violet light the chromatogram was always sprayed with Ehrlich's reagent and some hours later the intensities and sizes of the yellow spots were compared with those of the standards. Amounts less than 0.5 ug. usually did not show up, but for amounts greater than this there was never any great discrepancy between the values obtained by the two methods of comparison. Chromatograms developed in the phenol system were easily assessed by fluorescence in ultra-violet light and Ehrlich colour (pink), the paper being freed of phenol by benzen2 extraction followed by hanging in a current of warm air for two to three hours. In fact, in 80% of the assays to be reported duplicate chromatograms were thus run; there was always close agreement with the standard method using formate. After double ether extraction some chromatograms run in the butanol system and dried in warm air were sprayed with Gibbs' reagent followed by saturated sodium dihydrogen phosphate solution. This method of assessment was quite unsatisfactory as the initial spots of 3-HAA were rapidly obscured by several other closely situated substances (cf. Tompsett, 1959) .
It was found that urine acidified to pH 3 or thereabouts maintained its content of 3-HAA for many days when stored in the refrigerator. The ether extracts were unstable and were always assayed as soon as possible, usually on the day of preparation. Similarly the developed chromatograms were always assessed as soon as the papers were dry.
The possibility of completing the assay of 3-HAA by spectrofluorometric measurement was not investigated in this study.
Method
Preparation of Extract.-Urine was collected for 24 hours, 15 ml. of 10% H2S04 being used as preservative. To a filtered aliquot measuring 10% of the whole specimen was added one-tenth of its volume of concentrated HCI. The mixture was then shaken for two-minute periods with an equal volume of peroxidefree ether divided into four equal portions. Centrifugation was usually necessary to effect separation. After each extraction the ether layer was pipetted off and discarded. The pH of the aqueous phase was then adjusted with a volume of 10 N NaOH equiva!ent to that of the concentrated HCI previously used, followed by more dilute alkali until a pH of 3.5 was reached (B.D.H. 2540 indicator paper). Ether extraction was repeated with the same amounts as before. The four resulting ether fractions were combined and distilled to dryness at reduced pressure under nitrogen at a bath temperature not exceeding 400 C. The residue was taken up in four small successive amounts of ethanol and the solution was evaporated to a volume of 0.5 ml. This pale, strawcoloured solution was used. for chromatography.
The general chromatographic technique was that described by McMillan (1957) . The paper was marked out into four strips (each 2 cm. wide) for the urine extract (usually 0.01, 0.005, 0.0025, and 0.00125 ml.) and four for the standard 3-hydroxyanthranilic acid solution (2.0, 1.0, 0.5, and 0.25 /Lg.). Before use the standard was diluted 1 in 5 in ethanol from a stock refrigerated solution containing 20 mg./20 ml. ethanol to which 0.05 ml. of concentrated HCI had been added. The solvent (sodium formate 10 g., water 200 ml., formic acid I ml.) was renewed on each occasion. Two or three sheets of paper were hung in the same tank for two to three hours until the solvent front reached about 25 cm. A sheet of sponge rubber and a wrapper of cellophane paper were applied to the underside of the lid of the tank which was then quickly sealed by pressure from above (F. Albert-Recht, personal communication). The sheets were dried in the air at room temperature using a hair dryer. The amount of 3-hydroxyanthranilic acid in each of the four urine extract chromatograms was assessed visually by transmitted light from both the ultra-violet lamps previously described. The paper was then sprayed with Ehrlich's reagent and further comparisons made after about 18 hours.
Results
The excretion of 3-hydroxyanthranilic acid by 83 persons was determined. Twenty-five patients suffering from rheumatoid arthritis (all of whom were in-patients of the Rheumatic Unit, Northern General Hospital, Edinburgh) excreted quantities ranging from less than 125 ,ug. (the minimal amount detectable by the method) to 2,250 ,ug./ day, the average figure being 820 ,ug./day. In a few instances excretion was measured on more than one occasion, when values of the same order were found. The figures bore no relationship to the age or sex of the patient. The patients had received no steroid therapy or other drugs for at least three days before the urine was collected.
Twelve healthy laboratory workers excreted from less than 125 to 375 ,ug./day, the average being rather lower than 200 ,ug. / day. Fig. 1 shows that whereas only two of these normal persons excreted more than 250 jig./day, all rheumatoid subjects save three excreted 375 ,ug. or more/day. There would therefore appear to be some considerable difference between these two groups. One normal person who received heavy doses of either aspirin or panadol for three days showed the same low excretion three days later.
Analysis showed that the cases fell into two groups (Fig. 2) but 3-hydroxyanthranilic acid excretion showed values not in excess of those of normal persons (Fig. 1) . A larger group of 18 orthopaedic cases was studied. Of these patients, some were ambulant at the time of examination, some were more or less immobilized. Fig. 1 shows that in these cases the level of excretion of 3-hydroxyanthranilic acid was similar to that of normal persons, the average being 240 ,ug. (Fig. 4) , one case of ankylosing spondylitis showed a low excretion, as did a single case of disseminated lupus erythematosus receiving prednisolone. In two cases of psoriatic arthritis the excretion was low in one and very high in the other (1,750 ,g./day). Two patients who had undergone partial gastrectomy two days before the collection of urine showed a low excretion.
In Chromatographic examination of the urine in cases of rheumatoid arthritis for a strongly reducing substance has shown, however, that free 3-hydroxyanthranilic acid is excreted in increased amount as compared with normal subjects. The compound is known to be a normal metabolite of tryptophan; it is the immediate degradation product of 3-hydroxykynurenine and a precursor of nicotinic acid. It has so far been of limited medical interest, mainly as a possible carcinogen. Since the suggestion that o-aminophenols were carcinogenic (Bonser, Clayson, Jull, and Pyrah, 1954) , attention has been drawn to the two naturally occurring compounds, namely, 3-hydroxykynurenine and 3-hydroxyanthranilic acid, which have this structure. In fact, 3-hydroxyanthranilic acid was shown to produce cancer of the bladder in mice (Watson, 1956) and to be excreted in the unconjugated state in increased amount in human cancer of the bladder (Boyland and Williams, 1956 Parpajola (1956) reported that recession of fever did not arrest the excessive excretion of kynurenines. In a large series, the same authors (1955), using paper chromatography, found "very small amounts" of 3-HAA to be excreted by normal human subjects. In 11 out of 13 subjects with pulmonary tuberculosis excretion was definitely higher. Also in 59 out of 76 cases of leukaemia of various types, myelomatosis, Hodgkin's disease, and lymphosarcoma, considerable quantities of kynurenine and 3-hydroxykynurenine were found, but none was detectable in normal persons; no details were given in regard to 3-HAA, apart from a statement that excretion was raised in about one-third of the cases. The authors emphasized that the detection of tryptophan metabolites in human urine in the absence of special diets or administration of tryptophan was rare, and such excretion was linked with pathological conditions. An increased excretion of 3-HAA in any of the collagen diseases has not been reported previously. In the present series of cases the magnitude of the increase would appear to bear no relation to any of the major features of the disease except perhaps the E.S.R., where there was some proportionality, and the sensitized sheep cell test, which was always positive in association with the highest excretion rates. A high E.S.R. per se does not lead to increased excretion since many non-rheumatoid patients had a very high E.S.R. without such an increase. The rheumatoid patients had received no steroid or other drugs for at least three days before 3-HAA excretion was measured. A normal person who received heavy doses of either aspirin or panadol for three days showed no increase in 3-HAA excretion three days later. The effect of drugs on excretion by the rheumatoid patients was not investigated.
In agreement with Musajo et al. (1956) , no direct relationship was found between 3-HAA excretion and fever; but contrary to the above report no increase was found in active pulmonary tuberculosis.
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An increase in urinary 3-HAA could be due to increased tryptophan catabolism. However, many patients in whom tissue was probably wasting failed to show this effect and in rheumatoid arthritis itself there was no correlation with such wasting. Possibly 3-hydroxyanthranilic acid could accumulate as a result of enzymic imbalance such as can be produced in vivo in the case of certain other tryptophan metabolites by vitamin deficiency. Further insight into the abnormality in rheumatoid arthritis might be gained by studies along these lines.
